🇺🇸 FDA
Patent

US 10987399

Stable formulations for parenteral injection of peptide drugs

granted A61KA61K38/02A61K38/09

Quick answer

US patent 10987399 (Stable formulations for parenteral injection of peptide drugs) held by XERIS PHARMACEUTICALS, INC. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/02, A61K38/09, A61K38/16, A61K38/17